spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  efalizumab 

 HSMN NewsFeed - 8 Apr 2009
Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jan 2009
XOMA Announces Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2008
NICE Recommends Abbott's Adalimumab (HUMIRA(R)) for the Treatment of Chronic Plaque Psoriasis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
XOMA Appoints Mary L. Anderson as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2007
Steven Engle Appointed Chairman of XOMA
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2007
XOMA Appoints Steven B. Engle President, Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2007
XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 26 Feb 2007
XOMA Announces Planned Retirement of Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2007
Genentech Announces Positive Results from a Phase IV Study of Raptiva in Patients With Moderate-to-Severe Hand and Foot Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 6 Sep 2006
XOMA's NEUPREX(R) Granted Orphan Status in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Aug 2006
XOMA Unveils Strategy, Provides Update on NEUPREX(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Jul 2006
XOMA Suspends HepeX-B(TM) Work Following Cubist Decision
Biopharmaceuticals
 HSMN NewsFeed - 10 Apr 2006
Genentech Announces Vice President Appointments in Commercial Operations and Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2006
XOMA Announces Senior Management Appointments
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 25

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 25 additional stories matching:
efalizumab
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.